Healthcare -
Biotechnology - NASDAQ - US
$ 34.055
1.23 %
$ 14.8 B
Market Cap
17.83
P/E
RPRX - TOTAL RECEIVABLES
Total Receivables RPRX - Royalty Pharma plc
27 M
LAST VALUE
-80.76%
2 YEAR CAGR
-44.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR